Satellos to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
Satellos Bioscience Inc. (MSLE)
Company Research
Source: Business Wire
TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (Nasdaq: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company focused on restoring natural muscle repair and regeneration in degenerative muscle diseases, today announced that management will participate in a fireside chat at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 in NYC on Thursday, Feb. 12, 2026, at 10 a.m. ET.The fireside chat will be available via live webcast on the Events and Presentations page in the Investors section of the Company’s website. A replay will be available following the event.Members of the Satellos leadership team will also be available for one-on-one investor meetings during the conference. Investors interested in scheduling a meeting may contact their Guggenheim representative or reach out directly to Satellos at ir@satellos.com.ABOUT SATELLOS BIOSCIENCE INC.Satellos is a clinical-stage drug development company focused on restoring natural muscle re
Show less
Read more
Impact Snapshot
Event Time:
MSLE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MSLE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MSLE alerts
High impacting Satellos Bioscience Inc. news events
Weekly update
A roundup of the hottest topics
MSLE
News
- Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific ConferenceBusiness Wire
- Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular DystrophyBusiness Wire
- Satellos to Participate in Upcoming Investor ConferencesBusiness Wire
- Satellos Bioscience (NASDAQ:MSLE) is now covered by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>. They set a "sell (d-)" rating on the stock.MarketBeat
- Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular DystrophyBusiness Wire
MSLE
Sec Filings
- 2/24/26 - Form 6-K
- 2/19/26 - Form 6-K
- 2/18/26 - Form 6-K
- MSLE's page on the SEC website